George Bickerstaff Care Dx, Inc. (CDNA) insider trading activity

George Bickerstaff is of CareDx, Inc.. Currently has a direct ownership of 123,027 shares of CDNA, which is worth approximately $2.57 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 7,481 shares (Common Stock) at a price of $5.67 per share, resulting in proceeds of $42,417. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K

6.47% 3M change

23.37% 12M change

Total Value Held $2.57 Million

George Bickerstaff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2024	BUY Exercise of conversion of derivative security	$42,417 $5.67 p/Share	7,481 Added 5.73%	123,027 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,570 Added 8.38%	115,546 Common Stock
May 14 2024	BUY Exercise of conversion of derivative security	$52,550 $10.0 p/Share	5,255 Added 4.77%	104,976 Common Stock
Aug 11 2023	BUY Exercise of conversion of derivative security	$100,182 $5.15 p/Share	19,453 Added 16.32%	99,721 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	18,844 Added 19.01%	80,268 Common Stock
Jan 06 2023	BUY Grant, award, or other acquisition	-	1,323 Added 2.11%	61,424 Common Stock
Nov 23 2022	BUY Exercise of conversion of derivative security	$18,300 $1.22 p/Share	15,000 Added 19.97%	60,101 Common Stock
Oct 04 2022	BUY Grant, award, or other acquisition	-	986 Added 2.14%	45,101 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	812 Added 1.81%	44,115 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	4,863 Added 10.1%	43,303 Common Stock
May 09 2022	BUY Grant, award, or other acquisition	$5,009 $22.46 p/Share	223 Added 0.58%	38,440 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	481 Added 1.24%	38,217 Common Stock
Feb 28 2022	SELL Open market or private sale	$977,750 $39.11 p/Share	25,000 Reduced 39.85%	37,736 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	287 Added 0.46%	62,736 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	196 Added 0.31%	62,449 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	188 Added 0.3%	62,253 Common Stock
Jun 16 2021	BUY Grant, award, or other acquisition	-	1,127 Added 1.78%	62,065 Common Stock
May 21 2021	SELL Open market or private sale	$756,300 $75.63 p/Share	10,000 Reduced 14.1%	60,938 Common Stock
May 12 2021	SELL Open market or private sale	$633,900 $63.39 p/Share	10,000 Reduced 12.36%	70,938 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	193 Added 0.24%	80,938 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	258 Added 0.32%	80,745 Common Stock
Dec 14 2020	SELL Open market or private sale	$719,900 $71.99 p/Share	10,000 Reduced 11.05%	80,487 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	444 Added 0.49%	90,487 Common Stock

Also insider at

INVA

Innoviva, Inc. Healthcare

Director